Heinz Lehmann Award
This award is designed to recognize outstanding research achievements by Canadian scientists in the field of neuropsychopharmacology.
- Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm
- Interference with AMPA receptor endocytosis: effects on behavioural and neurochemical correlates of amphetamine sensitization in male rats
- Searching for an endogenous anti-Alzheimer molecule: identifying small molecules in the brain that slow Alzheimer disease progression by inhibition of β-amyloid aggregation
- Cytochrome P450–mediated drug metabolism in the brain
- A translational research approach to poor treatment response in patients with schizophrenia: clozapine–antipsychotic polypharmacy
- Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder
- Maternal programming of defensive responses through sustained effects on gene expression
Innovations in Neuropsychopharmacology Award
This award is designed to recognize outstanding and innovative research in the basic or clinical fields of neuropsychopharmacology
- Antipsychotic dosing: found in translation
- Magnetic resonance imaging and prediction of outcome in patients with major depression
Young Investigator Award
This award is designed to recognize outstanding contributions in the field of research in neuropsychopharmacology by an individual young basic scientist or clinical investigator in Canada
- The orbitofrontal cortex, food intake and obesity
- Inefficient neural system stabilization: a theory of spontaneous resolutions and recurrent relapses in psychosis
- Neuroanatomical phenotypes in mental illness: identifying convergent and divergent cortical phenotypes across autism, ADHD and schizophrenia
- Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology
- Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology
- Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions
- A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health
- Role of netrin-1 in the organization and function of the mesocorticolimbic dopamine system
- Perceived early-life maternal care and the cortisol response to repeated psychosocial stress
- The contribution of hypersalience to the “jumping to conclusions” bias associated with delusions in schizophrenia
- Relation between emotional face memory and social anhedonia in schizophrenia